Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction

Kidney International

Volumn 81, Issue 4, 2012, Pages 379-390

  Pindjakova, Jana ^a   Hanley, Shirley A ^a   Duffy, Michelle M ^a   Sutton, Caroline E ^b   Weidhofer, Gudrun A ^a   Miller, Melinda N ^c   Nath, Karl A ^c   Mills, Kingston H G ^b   Ceredig, Rhodri ^a   Griffin, Matthew D ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c MAYO CLINIC   (United States)

Author keywords

chemokine receptor; cytokines; inflammation; lymphocytes; obstructive nephropathy

Indexed keywords

BROXURIDINE; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL SELECTION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DYNAMICS; FEMALE; FLOW CYTOMETRY; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; KIDNEY DISEASE; KIDNEY OBSTRUCTION; LEUKOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; URETER OBSTRUCTION;

EID: 84856486599     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.348     Document Type: Article

References (54)

1. Bajwa A, Kinsey G, Okusa M. Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 2009; 10: 1196-1204.
2. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491. (Pubitemid 38981983)
3. Schrier RW, Wang W, Poole B et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114: 5-14. (Pubitemid 39071636)
4. Venkatachalam MA, Griffin KA, Lan R et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol-Renal Physiol 2010; 298: F1078-F1094.
5. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
6. Ysebaert DK, De Greef KE, De Beuf A et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491-496. (Pubitemid 38981984)
7. Tapmeier TT, Fearn A, Brown K et al. Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 2010; 78: 351-362.
8. Burne MJ, Daniels F, El Ghandour A et al. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283-1290. (Pubitemid 33107755)
9. Summers SA, Steinmetz OM, Li M et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 2009; 20: 2518-2524.
10. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009; 119: 1286-1297.
11. Mucida D, Cheroutre H, Sidonia F et al. The many face-lifts of CD4 T helper cells. Adv Immunol 2010; 107: 139-152.
12. Farrar JD, Asnagli H, Murphy KM. T helper subset development: roles of instruction, selection, and transcription. J Clin Invest 2002; 109: 431-435. (Pubitemid 34171771)
13. Moseley TA, Haudenschild DR, Rose L et al. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174. (Pubitemid 36389528)
14. Mills KHG. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008; 38: 2636-2649.
15. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350. (Pubitemid 46745409)
16. Woltman AM, De Haij S, Boonstra JG et al. Interleukin-17 and CD40- Ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 2000; 11: 2044-2055.
17. Paust H-J, Turner J-E, Steinmetz OM et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 2009; 20: 969-979.
18. Kitching AR, Holdsworth SR. The emergence of Th17 cells as effectors of renal injury. J Am Soc Nephrol 2011; 22: 235-238.
19. Turner J-E, Paust H-J, Steinmetz OM et al. The Th17 immune response in renal inflammation. Kidney Int 2010; 77: 1070-1075.
20. Dong X, Bachman LA, Miller MN et al. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int 2008; 74: 1294-1309.
21. Li L, Huang L, Vergis AL et al. IL-17 produced by neutrophils regulates IFN-g mediated neutrophil migration in mouse kidney ischemiareperfusion injury. J Clin Invest 2010; 120: 331-342.
22. Kryczek I, Banerjee M, Cheng P et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114: 1141-1149.
23. Acosta-Rodriguez EV, Rivino L, Geginat J et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-646. (Pubitemid 46785128)
24. Nakae S, Iwakura Y, Suto H et al. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007; 81: 1258-1268. (Pubitemid 46702045)
25. Acosta-Rodriguez E, Napolitani G, Lanzavecchia A et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-949. (Pubitemid 47300008)
26. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19: 281-286. (Pubitemid 46687011)
27. Manel N, Unutmaz D, Littman D. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgt. Nat Immunol 2008; 9: 641-649. (Pubitemid 351714729)
28. Volpe E, Servant N, Zollinger R et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008; 9: 650-657. (Pubitemid 351712635)
29. Sutton C, Brereton C, Keogh B et al. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006; 203: 1685-1691. (Pubitemid 44036274)
30. Chung Y, Chang SH, Martinez GJ et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signalling. Immunity 2009; 30: 576-587.
31. Liu H, Rohowsky-Kochan C. Regulation of IL-17 in human CCR6+ effector memory T cells. J Immunol 2008; 180: 7948-7957.
32. Ooi JD, Phoon RKS, Holdsworth SR et al. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol 2009; 20: 980-989.
33. Zhang Z, Kyttaris VC, Tsokos GC. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 2009; 183: 3160-3169.
34. Crisp?́n JC, Oukka M, Bayliss G et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-8766.
35. Shao X, Yang X, Zhao X et al. The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome. Ped Nephrol 2009; 24: 1683-1690.
36. Wang Y, Ito S, Chino Y et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 2010; 159: 1-10.
37. Gan P-Y, Steinmetz OM, Tan DSY et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 2010; 21: 925-931.
38. Nogueira E, Hamour S, Sawant D et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCAassociated vasculitis. Nephrol Dial Transplant 2010; 25: 2209-2217.
39. Deteix C, Attuil-Audenis V, Duthey A et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010; 184: 5344-5351.
40. Jones LK, O'Sullivan KM, Semple T et al. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant 2009; 24: 3024-3032.
41. Hsieh HG, Loong CC, Lui WY et al. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transplant Int 2001; 14: 287-298.
42. Van Kooten C, Boonstra JG, Paape ME et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998; 9: 1526-1534. (Pubitemid 28354565)
43. Sutton CE, Lalor SJ, Sweeney CM et al. Interleukin-1 and IL-23 induce innate IL-17 production from gd T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31: 331-341.
44. Steinmetz OM, Turner J-E, Paust H-J et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol 2009; 183: 4693-4704.
45. Turner J-E, Paust H-J, Steinmetz OM et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 2010; 21: 974-985.
46. Macconi D, Chiabrando C, Schiarea S et al. Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. J Am Soc Nephrol 2009; 20: 123-130.
47. Rees A. Cross dendritic cells anger T cells after kidney injury. J Am Soc Nephrol 2009; 20: 3-5.
48. Edgerton C, Crisp?́n JC, Moratz CM et al. IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol 2009; 130: 313-321.
49. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89-102.
50. Mills KHG, Dunne A. Immune modulation: IL-1, master mediator or initiator of inflammation. Nat Med 2009; 15: 1363-1364.
51. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005; 201: 1355-1359. (Pubitemid 40664079)
52. Timoshanko JR, Kitching AR, Iwakura Y et al. Contributions of IL-a and IL-b to crescentic glomerulonephritis in mice. J Am Soc Nephrol 2004; 15: 910-918. (Pubitemid 38375310)
53. Furuichi K, Wada T, Iwata Y et al. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemiareperfusion injury. Crit Care Med 2006; 34: 2447-2455. (Pubitemid 44260032)
54. Dong X, Swaminathan S, Bachman LA et al. Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int 2005; 68: 1096-1108. (Pubitemid 43246426)